| Literature DB >> 33768026 |
Rajam Nicholas1, Mandeep Singh Bindra2, Lydia Mathew1, Dharshini Sathishkumar1, Jeyaseelan Lakshmanan3, Renu George1.
Abstract
CONTEXT: Early diagnosis is the mainstay in the management of severe cutaneous adverse reactions (SCARs) to drugs. AIMS: To study the role of frozen section in the rapid diagnosis of SCARs and the impact on outcome of the affected patients. SETTINGS ANDEntities:
Keywords: SCARs; frozen section; outcome; rapid diagnosis
Year: 2021 PMID: 33768026 PMCID: PMC7982049 DOI: 10.4103/idoj.IDOJ_397_20
Source DB: PubMed Journal: Indian Dermatol Online J ISSN: 2229-5178
Histological features looked for in each of the conditions[9]
| Histological features | |
|---|---|
| TEN/SJS* | Epidermal necrosis |
| Necrotic keratinocytes | |
| Subepidermal bullae | |
| Mild dermal inflammatory infiltrate including eosinophils | |
| DRESS† | Apoptotic keratinocytes |
| Spongiosis | |
| Diffuse parakeratotic layer | |
| Lichenoid interface dermatitis | |
| Neutrophil exocytosis | |
| Dermal infiltrates including prominent eosinophils | |
| AGEP‡ | Subcorneal or intraepidermal pustules |
| Papillary dermal edema | |
| Lymphohistiocytic perivascular infiltrate with some eosinophils and neutrophils |
TEN/SJS*=Toxic epidermal necrolysis/Stevens-Johnson syndrome, DRESS†=Drug rash with eosinophilia and systemic symptoms, AGEP‡=Acute generalized exanthematous pustulosis
Figure 1Flowchart of study patients
Histological features of severe cutaneous adverse drug reactions - frozen and paraffin section findings
| Severe cutaneous adverse drug reactions | Histologic features | Frozen (%) | Paraffin (%) | |
|---|---|---|---|---|
| TEN* ( | Confluent necrosis | 83.3 | 83.3 | NA† |
| Occasional necrotic keratinocytes | 33.3 | 83.3 | 0.07 | |
| Basal cell vacuolation | 16.7 | 83.3 | 0.02 | |
| Subepidermal vesiculation | 100 | 100 | NA† | |
| Lymphocytic exocytosis | 16.7 | 83.3 | 0.02 | |
| Dermal inflammation | 100 | 100 | NA† | |
| SJS‡ ( | Confluent necrosis | 14.3 | 28.6 | 0.53 |
| Epidermal atrophy | 42.9 | 57.1 | 0.61 | |
| Epidermal apoptosis | 100 | 100 | NA† | |
| Basal cell vacuolation | 42.9 | 71.4 | 0.3 | |
| Subepidermal vesiculation | 14.3 | 14.3 | NA† | |
| Lymphocytic exocytosis | 57.1 | 71.4 | 0.58 | |
| Dermal inflammation | 100 | 100 | NA† | |
| DRESS§ ( | Parakeratosis | 17.6 | 58.8 | 0.01 |
| Epidermal apoptosis | 5.9 | 17.6 | 0.29 | |
| Spongiosis | 88.2 | 88.2 | NA† | |
| Focal basal cell vacuolation | 35.3 | 52.9 | 0.31 | |
| Lymphocytic exocytosis | 58.8 | 82.4 | 0.12 | |
| Eosinophilic infiltrate | 52.9 | 100 | 0.001 | |
| Dermal perivascular infiltrates of lymphocytes and histiocytes | 88.2 | 100 | 0.14 | |
| AGEP|| ( | Apoptotic keratinocytes | 0 | 50 | 0.24 |
| Spongiosis | 100 | 100 | NA† | |
| Neutrophilic spongiotic pustules | 50 | 50 | NA† | |
| Dermal lymphocytic infiltrate | 0 | 50 | 0.24 |
TEN* = Toxic epidermal necrolysis, NA† = not applicable, SJS‡ = Stevens Johnson syndrome, DRESS§ = Drug rash with eosinophilia and systemic symptoms, AGEP|| = Acute generalized exanthematous pustulosis
Comparative frequency of the salient histological features in severe cutaneous adverse reactions (SCARs)
| SCARs | Epidermal changes | Dermal changes Eosinophilic infiltrate | ||||||
|---|---|---|---|---|---|---|---|---|
| Confluent necrosis | Epidermal apoptosis | Parakeratosis | Spongiosis | Basal cell vacuolation | Neutrophilic spongiotic pustules | |||
| TEN* | Frozen ( | 5 (83.3) | 0 | 0 | 1 (16.7) | 1 (16.7) | 0 | 0 |
| Paraffin ( | 5 (83.3) | 1 (16.7) | 1 (16.7) | 5 (83.3) | 5 (83.3) | 0 | 4 (66.7) | |
| SJS‡ | Frozen ( | 1 (14.3) | 7 (100) | 1 (14.3) | 4 (57.1) | 3 (42.9) | 0 | 2 (28.6) |
| Paraffin ( | 2 (28.6) | 7 (100) | 2 (28.6) | 7 (100) | 5 (71.4) | 0 | 5 (71.4) | |
| DRESS§ | Frozen ( | 0 | 1 (5.9) | 3 (17.6) | 15 (88.2) | 6 (35.3) | 0 | 9 (52.9) |
| Paraffin ( | 0 | 3 (17.6) | 10 (58.8) | 15 (88.2) | 9 (52.9) | 0 | 17 (100) | |
| AGEP|| | Frozen ( | 0 | 0 | 0 | 2 (100) | 0 | 1 (50) | 1 (50) |
| Paraffin ( | 0 | 1 (50) | 1 (50) | 2 (100) | 1 (50) | 1 (50) | 1 (50) | |
TEN* = Toxic epidermal necrolysis, SJS‡ = Stevens Johnson syndrome, DRESS§ = Drug rash with eosinophilia and systemic symptoms, AGEP|| = Acute generalized exanthematous pustulosis
Figure 2Toxic epidermal necrolysis showing confluent epidermal necrosis. Hematoxylin and eosin (H&E) 100x, (a) frozen section, (b) paraffin section
Figure 3Stevens-Johnson syndrome showing epidermal atrophy, necrotic blister roof and sparse dermal inflammation. Hematoxylin and eosin (H&E) 100×, (a) frozen section, (b) paraffin section
Figure 4Drug rash with eosinophilia and systemic symptoms (DRESS) showing eosinophilic infiltrate. Hematoxylin and eosin (H&E) 200×, (a) frozen section, (b) paraffin section
Figure 5Acute generalized exanthematous pustulosis showing intraepidermal neutrophilic vesicles, spongiosis and moderate perivascular inflammation. Hematoxylin and eosin (H&E), (a) frozen section 200x, (b) paraffin section 100x
Sensitivity and specificity of frozen section diagnosis (n=32)
| A‡ | B§ | C|| | D¶ | Sensitivity (%) | Specificity (%) | PPV** (%) | NPV†† (%) | kappa | ||
|---|---|---|---|---|---|---|---|---|---|---|
| TEN/SJS* | 11 | 1 | 1 | 19 | 91.7 | 95 | 91.7 | 95 | 0.867 | <0.001 |
| DRESS† | 17 | 0 | 1 | 14 | 94.4 | 100 | 100 | 93.3 | 0.937 | <0.001 |
TEN/SJS* = Toxic epidermal necrolysis/Stevens Johnson syndrome, DRESS† = Drug rash with eosinophilia and systemic symptoms. A‡ - frozen section diagnosis positive, clinical diagnosis positive; B§ - frozen section diagnosis positive, clinical diagnosis negative; C|| - frozen section diagnosis negative, clinical diagnosis positive; D¶ - frozen section diagnosis negative, clinical diagnosis negative. PPV** - positive predictive value. NPV†† - negative predictive value. Sensitivity and specificity were not calculated for AGEP (acute generalized exanthematous pustulosis) since the numbers were very small